Pharmacodynamic evaluation of the novel vancomycin derivative LYSC98.
- DOI
- 10.1016/j.ejphar.2026.179465
- Published
- 2026 Dec 20
- Container
- European journal of pharmacology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ejphar.2026.179465,
title = {Pharmacodynamic evaluation of the novel vancomycin derivative LYSC98.},
author = {Wang XK and Li X and Lu FF and Wang PH and Wu HG and Ma MY and Hu XX and Nie TY and Li GQ and Li CR and Yang XY and You XF},
year = {2026},
journal = {European journal of pharmacology},
doi = {10.1016/j.ejphar.2026.179465},
url = {https://doi.org/10.1016/j.ejphar.2026.179465}
}RIS
TY - JOUR TI - Pharmacodynamic evaluation of the novel vancomycin derivative LYSC98. AU - Wang XK AU - Li X AU - Lu FF AU - Wang PH AU - Wu HG AU - Ma MY AU - Hu XX AU - Nie TY AU - Li GQ AU - Li CR AU - Yang XY AU - You XF PY - 2026 JO - European journal of pharmacology DO - 10.1016/j.ejphar.2026.179465 UR - https://doi.org/10.1016/j.ejphar.2026.179465 ER -
APA
XK, W., X, L., FF, L., PH, W., HG, W., MY, M., XX, H., TY, N., GQ, L., CR, L., XY, Y., & XF, Y. (2026). Pharmacodynamic evaluation of the novel vancomycin derivative LYSC98.. European journal of pharmacology. https://doi.org/10.1016/j.ejphar.2026.179465
Source records
- pubmed · retrieved 2026-11-10T11:09:25.304Z